Latest Strategic Transformation News

CONNEQT Health’s Pulse device sales surged to a $7 million annualised run-rate despite a temporary supply hiccup, while the company manages a tight cash runway supported by new R&D loans and related-party funding.

Bank of Queensland’s statutory profit fell 20% to $136 million in 1H26, weighed down by a $31 million loss on its equipment finance portfolio sale. The bank advances its digital transformation and plans a $3.7 billion capital release with Challenger Limited, maintaining strong capital and dividend guidance.

KMD Brands has reported solid half-year growth and launched a $65.3 million equity raising alongside debt refinancing to support its Next Level transformation strategy.

Webjet Group announces the resignation of CEO Katrina Barry, who led the company through a major demerger and strategic overhaul. The company reaffirms its FY26 EBITDA guidance despite ongoing leadership changes.

Ovanti Limited is reshaping its future with a strategic shift from its BNPL roots to a global financial Super App, exiting legacy US operations to focus on innovation and international expansion.

South Harz Potash Limited has raised A$1.25 million to fund exploration at its newly licensed copper-gold projects in Sweden, signalling a strategic pivot towards critical minerals and a planned rebrand to Turnstone Resources.

RooLife Group Ltd has reported a 144% surge in half-year revenue to $3.75 million, driven by strong growth in proprietary product sales, notably its RLG Coffee range in China. The company also reduced its net loss by 23%, reflecting operational improvements and strategic divestments.

WT Financial Group has reported robust half-year results for H1 FY2026, marked by a 20.8% increase in underlying net profit after tax and a fully franked interim dividend. The company’s strategic pivot to a business-to-business advice model and its Investco joint venture underpin its growth trajectory.

Patrys Limited reported a near doubling of its half-year loss to $3.02 million, driven by restructuring and a strategic pivot including the acquisition of Reliis Pty Ltd. The company is advancing a dual-platform biotech strategy combining a clinical-stage CNS asset with its proprietary antibody platform.

Emyria Limited has reported a significant 136% increase in revenue to $1.55 million for the half-year ended December 2025, driven by its expanding Empax clinic network and insurer-funded treatments across Australia. Despite this growth, the company posted a $2.37 million net loss, reflecting investments in scaling operations and infrastructure.

Duxton Farms Limited reported a significant half-year loss driven by acquisition and integration costs following a major portfolio expansion. The company is navigating a strategic shift towards diversified agriculture with plans to stabilise earnings over the coming years.

Southern Cross Media Group announces a significant reshuffle in its executive leadership following its recent merger, with CEO Jeff Howard stepping down and a global search underway for his successor.